Case report:: successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha

Case report:: successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha
复制标题

DOI:
10.1093/rheumatology/keh226
复制
发表时间:
2004-07-01
期刊:
影响因子:
5.5
通讯作者:
Büyükkidan, B
Büyükkidan, B
中科院分区:
医学1区
文献类型:
--
作者:
Korkmaz, C;Temiz, G;Büyükkidan, B

文献摘要

被引文献

相似文献

SIR,皮肌炎(DM)病程中可见呼吸系统并发症,但呼吸肌无力导致肺泡通气不足的报道并不常见[1, 2]。肺泡通气不足可能对常规药物产生耐药性,这可能导致死亡或依赖家庭机械通气 [2, 3]。我们介绍了一名患有肺泡通气不足的 DM 患者,该患者对联合免疫抑制治疗没有反应。开始抗肿瘤坏死因子-α(抗TNF-a)治疗后,她的通气功能不全得到了改善。一名19岁女孩因除了发声困难外还有吞咽困难1个月的病史入院。体检发现天芥菜皮疹和甲周红斑。她的近端肌肉力量为 2/5。她的红细胞沉降率(ESR)为28毫米/小时。血清肌酶水平升高:肌酐激酶(CK)3050 U/l(正常16-190)、乳酸脱氢酶(LDH)1257U/l(正常240-480)、天冬氨酸转氨酶(AST)284U/l(正常0-40)、丙氨酸
SIR, Respiratory complications can be seen in the course of dermatomyositis (DM), but alveolar hypoventilation due to respiratory muscle weakness has only been infrequently reported [1, 2]. Alveolar hypoventilation can be resistant to conventional agents, which may result in either death or dependence on home mechanical ventilation [2, 3].We present a patient with DM with alveolar hypoventilation who failed to respond to a combined immunosuppressive treatment. The initiation of anti-tumour necrosis factor-alpha (anti-TNF-a) resulted in improvement in her ventilatory insufficiency. A 19-yr-old girl was admitted to hospital with a 1-month history of having difficulty in swallowing apart from dysphonia. Physical examination disclosed heliotrope rashes and periungual erythema. Her proximal muscle power was 2/5. Her erythrocyte sedimentation rate (ESR) was 28mm/h. Serum levels of muscle enzymes were increased: creatinine kinase (CK) 3050 U/l (normal 16–190), lactate dehydrogenase (LDH) 1257U/l (normal 240–480), aspartate aminotransferase (AST) 284U/l (normal 0–40), alanine